Related Experiment Video

Updated: Jul 24, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K

In ACS with multivessel CAD, immediate vs. staged complete revascularization was noninferior for a composite outcome

Manoj Kesarwani1

  • 1University of California, Davis School of Medicine, Sacramento, California, USA (M.K.).

Annals of Internal Medicine
|July 3, 2023
PubMed

Insights

Immediate complete revascularization is non-inferior to staged procedures for acute coronary syndrome patients with multivessel disease. This finding supports timely intervention in managing complex coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Acute coronary syndrome (ACS) with multivessel coronary disease (MVD) requires prompt management.
  • The optimal timing for complete revascularization in ACS patients with MVD remains debated.
  • Previous studies have yielded conflicting results regarding immediate versus staged revascularization strategies.

Purpose of the Study:

  • To determine if immediate complete revascularization is non-inferior to staged complete revascularization in patients with ACS and MVD.
  • To compare clinical outcomes between immediate and staged revascularization strategies.

Main Methods:

  • A prospective, open-label, non-inferiority, randomized controlled trial (BIOVASC).
  • Included patients presenting with ACS and MVD.
  • Randomized participants to either immediate or staged complete revascularization.

Main Results:

  • Immediate complete revascularization was found to be non-inferior to staged complete revascularization.
  • Key adverse cardiovascular events did not significantly differ between the two strategies.
  • The study provides robust evidence supporting the safety and efficacy of immediate revascularization.

Conclusions:

  • Immediate complete revascularization is a viable and safe strategy for patients with acute coronary syndrome and multivessel coronary disease.
  • The findings suggest that timely intervention can be prioritized without compromising patient outcomes.
  • This trial contributes significant data to guide clinical decision-making in ACS management.
Abstract

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

780

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
32
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10